J. Spellman

发表

Corneal protection by the ocular mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced corneal defect.

J. Yanni, D. Gamache, Zhong-you Wei, 2002, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.

S. Xu, N. Sharif, J. Yanni, 1999, Archives of ophthalmology.

A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.

N. Sharif, J. Yanni, S. Miller, 1999, Acta ophthalmologica Scandinavica. Supplement.

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.

S. W. Jordan, J. Yuhas, F. Culo, 1980, British Journal of Cancer.

Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.

N. Sharif, J. Yanni, S. Miller, 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Transient loss of prostaglandin synthetic capacity in rabbit iris-ciliary body following anterior chamber paracentesis.

J. Yanni, D. Gamache, J. Spellman, 1998, Ocular immunology and inflammation.

The immune and mitogenic response by Balb/c, C3H/HeJ, and nude mice to Brucella abortus bacterin and endotoxin

J. Spellman, 1976 .

The role of WR-2721 in radiotherapy and/or chemotherapy.

J. Yuhas, F. Culo, J. Spellman, 1980, Cancer clinical trials.

Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular Barriers

J. Yanni, J. Spellman, G. Graff, 2000, Inflammation.

Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: I. Assessment of Anti-Inflammatory Efficacy

J. Yanni, D. Gamache, J. Spellman, 2000, Inflammation.

Preservation of corneal integrity by the mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced dry eye.

J. Yanni, D. Gamache, Zhong-you Wei, 2000, Advances in experimental medicine and biology.

Pharmacological validation of a feline model of steroid-induced ocular hypertension.

J. Yanni, C. Paterson, J. Spellman, 1999, Archives of ophthalmology.

Secretion of proinflammatory cytokines by human conjunctival epithelial cells.

J. Yanni, S. Dimitrijevich, D. Gamache, 1997, Ocular immunology and inflammation.

Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.

J. Yanni, J. Spellman, D. Stephens, 1994, Journal of ocular pharmacology.

The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.

J. Yanni, S. Miller, D. Gamache, 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Immune and mitogenic responses by BALB/c, C3H/HeJ, and nude mice to Brucella abortus bacterin and lipopolysaccharide

J. Spellman, N. D. Reed, 1979, Infection and immunity.

Improved myeloperoxidase assay for quantitation of neutrophil influx in a rat model of endotoxin-induced uveitis.

J. Yanni, D. Gamache, J. Spellman, 1998, Journal of pharmacological and toxicological methods.

Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats.

J. Yanni, S. Robertson, L. Weimer, 1993, International archives of allergy and immunology.

Secretory response of mast cells contained in monodispersed human choroidal preparations.

J. Yanni, S. Miller, D. Gamache, 1997, International archives of allergy and immunology.

Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: linkage to convulsions and electroencephalography trait.

M. T. Medina, M. Gee, J. Serratosa, 1995, American journal of human genetics.

Juvenile myoclonic epilepsy in chromosome 6p12-p11: locus heterogeneity and recombinations.

M. T. Medina, M. Gee, J. Serratosa, 1996, American journal of medical genetics.

Human conjunctival mast cell responses in vitro to various secretagogues.

J. Yanni, F. Graziano, S. Miller, 1996, Ocular immunology and inflammation.

A comparison of the effects of olopatadine and ketotifen on model membranes.

J. Yanni, H. Brockman, J. Spellman, 2000, Acta ophthalmologica Scandinavica. Supplement.

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.

S. W. Jordan, J. Yuhas, F. Culo, 1980, British Journal of Cancer.